Cargando…
Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates
CONTEXT: The treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is consistently difficult. Besides resistances, drug availability can be problematic and costs for therapy are high. AIMS: Our aim was to evaluate alternatives in treatment of MDR and XDR TB ot...
Autores principales: | Schönfeld, Nicolas, Bergmann, Thorsten, Vesenbeckh, Silvan, Mauch, Harald, Bettermann, Gudrun, Bauer, Torsten T., Rüssmann, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519013/ https://www.ncbi.nlm.nih.gov/pubmed/23243341 http://dx.doi.org/10.4103/0970-2113.102794 |
Ejemplares similares
-
The Use of Interferon Gamma Release Assays in the Diagnosis of Active Tuberculosis
por: Vesenbeckh, Silvan M., et al.
Publicado: (2012) -
The Correlations of Minimal Inhibitory Concentration Values of Anti-TB Drugs with Treatment Outcomes and Clinical Profiles in Patients with Multidrug-Resistant Tuberculosis (MDR-TB) in China
por: Tang, Qin, et al.
Publicado: (2022) -
Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022) -
Minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: An integrated approach for multidrug-resistant tuberculosis
por: Srivastava, Shashikant
Publicado: (2015) -
Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
por: Davies Forsman, Lina, et al.
Publicado: (2018)